Page 838 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 51 Congenital Disorders of Lymphocyte Function 723.e1

REFERENCES 22. Coffey AJ, Brooksbank RA, Brandau O, et al: Host response to EBV
infection in X-linked lymphoproliferative disease results from muta-
1. Abdollahpour H, Appaswamy G, Kotlarz D, et al: The phenotype of tions in an SH2-domain encoding gene. Nat Genet 20(2):129–135,
human STK4 deficiency. Blood 119(15):3450–3457, 2012. 1998.
2. Aiuti A, Biasco L, Scaramuzza S, et al: Lentiviral hematopoietic stem 23. Conley ME, Dobbs KA, Farmer AK, et al: Primary B cell immunode-
cell gene therapy in patients with Wiskott-Aldrich syndrome. Science ficiencies: comparisons and contrasts. Annu Rev Immunol 27:199–227,
341(6148):1233151, 2013. 2009.
3. Aiuti A, Cattaneo F, Galimberti S, et al: Gene therapy for immu- 24. Courtois G, Smahi A, Reichenbach J, et al: A hypermorphic Ikap-
nodeficiency due to adenosine deaminase deficiency. N Engl J Med paBalpha mutation is associated with autosomal dominant anhidrotic
360(5):447–458, 2009. ectodermal dysplasia and T cell immunodeficiency. J Clin Invest
4. Alangari A, Alsultan A, Adly N, et al: LPS-responsive beige-like anchor 112(7):1108–1115, 2003.
(LRBA) gene mutation in a family with inflammatory bowel disease and 25. Crank MC, Grossman JK, Moir S, et al: Mutations in PIK3CD can
combined immunodeficiency. J Allergy Clin Immunol 130(2):481–482, cause hyper IgM syndrome (HIGM) associated with increased cancer
2012. susceptibility. J Clin Immunol 34(3):272–276, 2014.
5. Al-Herz W, Bousfiha A, Casanova J-L, et al: Primary immunodeficiency 26. Crequer A, Troeger A, Patin E, et al: Human RHOH deficiency causes
diseases: an update on the classification from the international union T cell defects and susceptibility to EV-HPV infections. J Clin Invest
of immunological societies expert committee for primary immunodefi- 122(9):3239–3247, 2012.
ciency. Front Immunol 5:162, 2014. 27. Crequer A, Picard C, Patin E, et al: Inherited MST1 deficiency
6. Arnaiz-Villena A, Timon M, Corell A, et al: Brief report: primary underlies susceptibility to EV-HPV infections. PLoS ONE 7(8):e44010,
immunodeficiency caused by mutations in the gene encoding the 2012.
CD3-gamma subunit of the T-lymphocyte receptor. N Engl J Med 28. Dadi HK, Simon AJ, Roifman CM: Effect of CD3delta deficiency on
327(8):529–533, 1992. maturation of alpha/beta and gamma/delta T-cell lineages in severe
7. Arpaia E, Shahar M, Dadi H, et al: Defective T cell receptor signaling combined immunodeficiency. N Engl J Med 349(19):1821–1828,
and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 2003.
76(5):947–958, 1994. 29. de Saint Basile G, Ménasché G, Latour S: Inherited defects causing
8. Bennett CL, Christie J, Ramsdell F, et al: The immune dysregulation, hemophagocytic lymphohistiocytic syndrome. Ann N Y Acad Sci
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused 1246(1):64–76, 2011.
by mutations of FOXP3. Nat Genet 27(1):20–21, 2001. 30. Deau M-C, Heurtier L, Frange P, et al: A human immunodeficiency
9. Boerkoel CF, Takashima H, John J, et al: Mutant chromatin remodeling caused by mutations in the PIK3R1 gene. J Clin Invest 124(9):3923–
protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat 3928, 2014.
Genet 30(2):215–220, 2002. 31. Derry JM, Ochs HD, Francke U: Isolation of a novel gene mutated in
10. Boisson-Dupuis S, Kong X-F, Okada S, et al: Inborn errors of human Wiskott-Aldrich syndrome. Cell 78(4):635–644, 1994.
STAT1: allelic heterogeneity governs the diversity of immunological 32. Dobbs K, Domínguez Conde C, Zhang S-Y, et al: Inherited DOCK2
and infectious phenotypes. Curr Opin Immunol 24(4):364–378, Deficiency in Patients with Early-Onset Invasive Infections. N Engl J
2012. Med 372(25):2409–2422, 2015.
11. Boztug K, Schmidt M, Schwarzer A, et al: Stem-cell gene therapy for 33. Elder ME, Lin D, Clever J, et al: Human severe combined immuno-
the Wiskott-Aldrich syndrome. N Engl J Med 363(20):1918–1927, deficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science
2010. 264(5165):1596–1599, 1994.
12. Braun CJ, Boztug K, Paruzynski A, et al: Gene therapy for Wiskott- 34. Engelhardt KR, McGhee S, Winkler S, et al: Large deletions and
Aldrich syndrome—long-term efficacy and genotoxicity. Sci Transl Med point mutations involving the dedicator of cytokinesis 8 (DOCK8)
6(227):227ra33–3, 2014. in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin
13. Buckley RH: Transplantation of hematopoietic stem cells in human Immunol 124(6):1289–1302, e4, 2009.
severe combined immunodeficiency: longterm outcomes. Immunol Res 35. Ferrari S, Giliani S, Insalaco A, et al: Mutations of CD40 gene cause
49(1–3):25–43, 2011. an autosomal recessive form of immunodeficiency with hyper IgM. Proc
14. Burns SO, Zenner HL, Plagnol V, et al: LRBA gene deletion in a patient Natl Acad Sci USA 98(22):12614–12619, 2001.
presenting with autoimmunity without hypogammaglobulinemia. J 36. Feske S, Gwack Y, Prakriya M, et al: A mutation in Orai1 causes
Allergy Clin Immunol 130(6):1428–1432, 2012. immune deficiency by abrogating CRAC channel function. Nature
15. Candotti F, Shaw KL, Muul L, et al: Gene therapy for adenosine 441(7090):179–185, 2006.
deaminase-deficient severe combined immune deficiency: clinical com- 37. Feske S: Immunodeficiency due to defects in store-operated calcium
parison of retroviral vectors and treatment plans. Blood 120(18):3635– entry. Ann N Y Acad Sci 1238:74–90, 2011.
3646, 2012. 38. Finnish-German APECED Consortium: An autoimmune disease,
16. Casanova J-L, Holland SM, Notarangelo LD: Inborn errors of human APECED, caused by mutations in a novel gene featuring two PHD-
JAKs and STATs. Immunity 36(4):515–528, 2012. type zinc-finger domains. Nat Genet 17(4):399–403, 1997.
17. Castigli E, Wilson SA, Garibyan L, et al: TACI is mutant in common 39. Fischer A, Le Deist F, Hacein-Bey-Abina S, et al: Severe combined
variable immunodeficiency and IgA deficiency. Nat Genet 37(8):829– immunodeficiency. A model disease for molecular immunology and
834, 2005. therapy. Immunol Rev 203:98–109, 2005.
18. Chan AC, Kadlecek TA, Elder ME, et al: ZAP-70 deficiency in an 40. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M: Gene therapy
autosomal recessive form of severe combined immunodeficiency. Science for primary adaptive immunodeficiencies. J Allergy Clin Immunol
264(5165):1599–1601, 1994. 127(6):1356–1359, 2011.
19. Chapel H, Cunningham-Rundles C: Update in understanding common 41. Frank J, Pignata C, Panteleyev AA, et al: Exposing the human nude
variable immunodeficiency disorders (CVIDs) and the management phenotype. Nature 398(6727):473–474, 1999.
of patients with these conditions. Br J Haematol 145(6):709–727, 42. Gaspar HB, Cooray S, Gilmour KC, et al: Hematopoietic stem cell
2009. gene therapy for adenosine deaminase-deficient severe combined
20. Chase NM, Verbsky JW, Routes JM: Newborn screening for immunodeficiency leads to long-term immunological recovery and
T-cell deficiency. Curr Opin Allergy Clin Immunol 10(6):521–525, metabolic correction. Sci Transl Med 3(97):97ra80, 2011.
2010. 43. Gaspar HB, Cooray S, Gilmour KC, et al: Long-term persistence of
21. Chen R, Giliani S, Lanzi G, et al: Whole-exome sequencing identifies a polyclonal T cell repertoire after gene therapy for X-linked severe
tetratricopeptide repeat domain 7A (TTC7A) mutations for combined combined immunodeficiency. Sci Transl Med 3(97):97ra79, 2011.
immunodeficiency with intestinal atresias. J Allergy Clin Immunol 44. Gennery AR, Slatter MA, Grandin L, et al: Transplantation of hemato-
132(3):656–664, e17, 2013. poietic stem cells and long-term survival for primary immunodeficiencies